New Delhi [India], January 10 (ANI): Omicron is behaving very mildly and rarely affecting newborn babies, a senior doctor at Max Smart Super Specialty Hospital, Saket said on Monday.
Berlin [Germany], January 3 (ANI/Xinhua): Germany's seven-day COVID-19 incidence rose for the fifth consecutive day, up from 222.7 on the previous day to 232.4, the Robert Koch Institute (RKI) for infectious diseases said on Monday.
Gaithersburg/Pune (Maryland/Maharashtra)[US/India], December 29 (ANI): Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India (SII), the world's largest vaccin
Bogota [Colombia], December 21 (ANI/Sputnik): Colombia has identified three cases of the Omicron coronavirus strain in people arriving from abroad, the first indication that the highly infectious variant has spread to the Latin American nation, the Ministry of Health and Social Protection sa
Tehran [Iran], December 19 (ANI/Xinhua): Iran identified the first case of the COVID-19 Omicron variant, Mohammad Mehdi Gooya, the head of management center of infectious diseases of Iran's Health Ministry, announced on Sunday.
Arlington [US], December 16 (ANI): A new study has provided guidance for increasing the effectiveness of face masks to reduce the spread of respiratory infectious pathogens including SARS-CoV-2.
Washington [US], December 8 (ANI): Amid the cloud of concerns regarding the Omicron coronavirus variant, National Institute of Allergy and Infectious Diseases Director Dr Anthony Fauci on Tuesday said emerging evidence suggests that Omicron has increased infectivity and not a "severe prof
Toronto [Canada], November 25 (ANI): Researchers at the University of Toronto have discovered that an overlooked gene plays a major role in the development of antibodies, which help the immune system recognize and fight viruses including SARS-CoV-2, bacteria and other causes of infectious di
New Delhi [India], November 25 (ANI): Commenting on the study of the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obt
New Delhi [India], November 24 (ANI): Two doses of COVID-19 vaccine Covaxin (BBV152) are 50 per cent effective against symptomatic COVID-19 disease, according to the first real-world assessment of the COVID-19 vaccine published in the Lancet Infectious Diseases journal.
Berlin [Germany], November 17 (ANI/Xinhua): The number of daily COVID-19 cases in Germany hit a new record of 52,826, the Robert Koch Institute (RKI) for infectious diseases said Wednesday.
Oslo [Norway], Russia, November 15 (ANI/Sputnik): A new variant of the Delta strain of the coronavirus has been detected in Norway, which is assumed to be no more infectious than other strains, the NRK broadcaster reported Monday, citing the Norwegian Institute of Public Health (NIPH).